Studies have found reduced GLUT4 expression in epicardial adipose tissue [88,89] and skeletal muscle [90] among obese patients with CAD and insulin resistance, suggesting a potential role of GLUT4 in the development of CAD and its associated metabolic abnormalities. Here, SLC2A4 is linked to Insulin resistance.